By Prof. Rajesh N. Davé, Distinguished Professor, Chemical & Materials Engineering, New Jersey Institute of Technology, Newark, NJ 07102 Distinguished Professor of Chemical, Biological and Pharmaceutical Engineering, Center for...
Prof. Rajesh Davé Fellow of the American Institute of Chemical Engineers (AIChE), American Association of Pharmaceutical Scientists (AAPS), and National Academy of Inventors (NAI) is a Distinguished Professor of...
VP, head of CMC, Supply Chain and QA Chong-Hui Gu, Ph. D, is responsible for CMC, supply chain and QA at Foghorn Therapeutics. He has over 20 years of...
By Dr. Bo Wang, Ph.D. Biogen, Cambridge, MA Absolute configuration determination of an active pharmaceutic ingredient (API) is a crucial task in drug development. Tremendous scientific and technical progress...
Bo Wang obtained his bachelor’s degree in Pharmaceutical Engineering at Southeast University in China. He then completed his Ph.D. study in physical organic chemistry at Kansas State University. After...
By Dedong Wu, Ph.D. Advanced Drug Delivery, PharmSci, R&D, AstraZeneca, Boston US dedong.wu@astrazeneca.com It is challenging and laborious to identify a crystallization process to access an optimal drug substance...
Dedong Wu is an associate principal scientist in Advance Drug Delivery at AstraZeneca. He provides expertise in the areas of drug substance form selection, enabling formulation, targeted drug delivery...
Haitao Zhang is an Associate Research Fellow in Chemical Development with Sumitomo Pharma America since 2012. In the current role, he is responsible for in developing, and demonstrating commercially...
By Haitao Zhang, Ph.D. Associate Research Fellow, Sumitomo Pharma America, Inc. The crystallization of active pharmaceutical ingredients, particularly those with multiple polymorphic forms, particle size and morphology critical properties,...
